SUNPHARMA Financial Statements

SUNPHARMA Annual Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 2.01 24 (16) 10.90
Op profit growth 21.40 24.40 (44) 23.70
EBIT growth 30 12.70 (48) 21.50
Net profit growth (23) 74.20 (69) 53.20
Profitability ratios (%)        
OPM 25.30 21.20 21.20 31.90
EBIT margin 21.60 17 18.70 29.90
Net profit margin 8.67 11.50 8.16 22.10
RoCE 12.80 9.96 9.46 19.40
RoNW 1.58 2.25 1.44 5
RoA 1.28 1.68 1.03 3.58
Per share ratios ()        
EPS 9.52 17.50 10.70 32.70
Dividend per share 7.50 4 2 3.50
Cash EPS 3.43 7.14 2.76 23.80
Book value per share 194 189 160 153
Valuation ratios        
P/E 62.80 20.20 46.30 21.10
P/CEPS 174 49.40 180 28.90
P/B 3.09 1.87 3.10 4.50
EV/EBIDTA 15.10 11.30 18.50 14.90
Payout (%)        
Dividend payout -- -- 22.20 12.10
Tax payout (7.20) (16) (19) (13)
Liquidity ratios        
Debtor days 101 95.80 103 80.80
Inventory days 91.90 82 94.50 76.60
Creditor days (58) (62) (85) (71)
Leverage ratios        
Interest coverage (51) (18) (9.60) (24)
Net debt / equity (0.10) 0.04 0.01 (0.10)
Net debt / op. profit (0.30) 0.26 0.08 (0.50)
Cost breakup ()        
Material costs (26) (28) (28) (26)
Employee costs (20) (19) (20) (16)
Other costs (28) (31) (31) (27)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 33,498 32,838 26,489 31,578
yoy growth (%) 2.01 24 (16) 10.90
Raw materials (8,690) (9,230) (7,425) (8,131)
As % of sales 25.90 28.10 28 25.70
Employee costs (6,862) (6,362) (5,367) (4,902)
As % of sales 20.50 19.40 20.30 15.50
Other costs (9,478) (10,271) (8,090) (8,456)
As % of sales 28.30 31.30 30.50 26.80
Operating profit 8,468 6,974 5,608 10,089
OPM 25.30 21.20 21.20 31.90
Depreciation (2,080) (2,053) (1,500) (1,265)
Interest expense (141) (303) (518) (400)
Other income 859 652 839 623
Profit before tax 7,106 5,270 4,429 9,048
Taxes (515) (823) (845) (1,212)
Tax rate (7.20) (16) (19) (13)
Minorities and other 619 (422) (472) (872)
Adj. profit 7,210 4,026 3,112 6,964
Exceptional items (4,306) (261) (951) --
Net profit 2,904 3,765 2,162 6,964
yoy growth (%) (23) 74.20 (69) 53.20
NPM 8.67 11.50 8.16 22.10
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 7,106 5,270 4,429 9,048
Depreciation (2,080) (2,053) (1,500) (1,265)
Tax paid (515) (823) (845) (1,212)
Working capital 9,890 11,120 8,793 10,021
Other operating items -- -- -- --
Operating cashflow 14,401 13,515 10,878 16,592
Capital expenditure 30,260 28,667 18,240 13,981
Free cash flow 44,661 42,182 29,117 30,574
Equity raised 52,835 53,528 51,415 48,626
Investments 7,383 7,930 4,731 (1,594)
Debt financing/disposal 4,075 8,372 10,435 12,243
Dividends paid -- -- 480 840
Other items -- -- -- --
Net in cash 108,953 112,012 96,178 90,688
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 240 240 240 240
Preference capital -- -- -- --
Reserves 46,223 45,025 41,169 38,074
Net worth 46,463 45,264 41,409 38,314
Minority interest
Debt 3,869 8,315 10,514 10,385
Deferred tax liabilities (net) 1,200 1,024 990 907
Total liabilities 54,549 58,464 56,227 53,491
Fixed assets 23,120 24,067 23,248 21,318
Intangible assets
Investments 9,612 10,143 7,903 7,143
Deferred tax asset (net) 4,712 4,142 3,441 3,096
Net working capital 10,659 13,625 14,361 12,005
Inventories 8,997 7,875 7,886 6,881
Inventory Days 98 87.50 -- 94.80
Sundry debtors 9,061 9,421 8,884 7,815
Debtor days 98.70 105 -- 108
Other current assets 6,874 7,083 6,943 9,023
Sundry creditors (4,312) (3,664) (4,270) (5,180)
Creditor days 47 40.70 -- 71.40
Other current liabilities (9,962) (7,090) (5,083) (6,534)
Cash 6,446 6,488 7,276 9,929
Total assets 54,549 58,464 56,227 53,491
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017
Gross Sales 33,233 32,325 28,686 26,066 30,264
Excise Duty -- -- -- -- --
Net Sales 33,233 32,325 28,686 26,066 30,264
Other Operating Income 265 512 380 424 1,314
Other Income 836 636 1,025 839 623
Total Income 34,334 33,473 30,091 27,328 32,202
Total Expenditure ** 29,313 26,108 23,973 21,832 21,489
PBIDT 5,021 7,365 6,119 5,496 10,712
Interest 141 303 555 518 400
PBDT 4,879 7,062 5,563 4,979 10,313
Depreciation 2,080 2,053 1,753 1,500 1,265
Minority Interest Before NP -- -- -- -- --
Tax 515 823 601 911 1,212
Deferred Tax -- -- -- -- --
Reported Profit After Tax 2,285 4,187 3,209 2,568 7,836
Minority Interest After NP (631) 407 542 447 882
Net Profit after Minority Interest 2,904 3,765 2,665 2,096 6,964
Extra-ordinary Items (3,514) (218) (1,023) (702) --
Adjusted Profit After Extra-ordinary item 6,418 3,983 3,688 2,797 6,964
EPS (Unit Curr.) 12.10 15.70 11.10 8.73 29
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) 750 400 275 200 350
Equity 240 240 240 240 240
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 15.10 22.80 21.30 21.10 35.40
PBDTM(%) 14.70 21.80 19.40 19.10 34.10
PATM(%) 6.87 13 11.20 9.85 25.90
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity